48 filings
Page 2 of 3
8-K/A
1sii jkww1u3hvj4j
22 Sep 22
Submission of Matters to a Vote of Security Holders
7:41am
8-K
64w5a
4 Aug 22
C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:15am
8-K
pafpc
2 Aug 22
C4 Therapeutics Appoints Experienced Clinical Development Leaders Laura Bessen, M.D. and Donna Grogan, M.D. to Board of Directors
8:33am
8-K
peh651d0mqjf2p2 kb8i
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
c0clks8
17 Jun 22
Departure of Directors or Certain Officers
4:05pm
8-K
xsv8ior
16 May 22
Other Events
4:57pm
8-K
afrf eefw14o6bsheo
5 May 22
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
8:06am
8-K
miyzm5m4wpxrep52qtv
8 Apr 22
C4 Therapeutics Presents Clinical Data from Cohort A of the Ongoing Phase 1/2 Clinical Trial of CFT7455, a Novel IKZF1/3 Degrader
1:21pm
8-K
661emgub
16 Mar 22
C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
4:15pm
8-K
9ytqobk2 1zohsje5k
24 Feb 22
C4 Therapeutics Reports Full Year 2021 Financial Results and Recent Business Highlights
7:30am
8-K/A
nv3qb8cr5wv 5fl
21 Jan 22
Financial Statements and Exhibits
4:12pm
8-K
htklvdo ower
10 Jan 22
C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio
7:45am
8-K
lqc6641 9wwqxme8
30 Nov 21
Entry into a Material Definitive Agreement
4:18pm
8-K
omgq3
10 Nov 21
C4 Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Results
4:12pm
8-K
tp6nebvy 60
11 Aug 21
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
4:07pm
8-K
gm13km6 h61cnrs2
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:26pm
8-K
fkp dzt0j5f
14 Jun 21
Other Events
4:17pm
8-K
wg8bjk
7 Jun 21
C4 Therapeutics Presents Pre-clinical Data on CFT8919, A Selective Degrader of EGFR L858R, at Keystone Symposium on Targeted Protein Degradation
7:25am
8-K
ekp8ezz0 q0r6
26 May 21
Regulation FD Disclosure
4:28pm
8-K
bytjc0eecj8y7
20 May 21
C4 Therapeutics Appoints Lauren White as Chief Financial Officer
4:22pm